Entering text into the input field will update the search result below

Rhythm Pharmaceuticals, Inc. (RYTM) CEO David Meeker on Q3 2021 Results - Earnings Call Transcript

Nov. 02, 2021 1:36 PM ETRhythm Pharmaceuticals, Inc. (RYTM)
SA Transcripts profile picture
SA Transcripts

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q3 2021 Earnings Conference Call November 2, 2021 8:00 AM ET

Company Participants

David Connolly - Head of Investor Relations & Corporate Communications

David Meeker - Chairman, President & Chief Executive Officer

Linda Shapiro - Chief Medical Officer

Jennifer Chien - Executive Vice President, Head of North America

Hunter Smith - Chief Financial Officer

Conference Call Participants

Phil Nadeau - Cowen and Co.

Joseph Stringer - Needham & Company

Corinne Jenkins - Goldman Sachs


Good day and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Third Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised today’s conference is being recorded. [Operator Instructions]

I would now like to hand the conference over to our speaker today, David Connolly with Rhythm Pharmaceuticals. Please go ahead.

David Connolly

Thank you, and good morning. I'm David Connolly, Head of IR and Corporate Communications here at Rhythm Pharmaceuticals. For those of you participating via conference call, the accompanying slides can be accessed and controlled by going to the Events section of the Investors page on our website at ir.rhythmtx.com.

This morning we issued a press release that provides our third quarter 2021 financial results and business update, which is available on our website. As listed on slide 2 with me today here in Boston for the conference call are David Meeker, Chair, President and Chief Executive Officer of Rhythm; Linda Shapiro, our Chief Medical Officer; Jennifer Chien, Executive Vice President Head of North America; and Hunter Smith, our Chief Financial Officer.

With slide 3, I'll remind you that this call contains remarks concerning future expectations, plans and prospects, which constitute forward-looking statements. Actual results may differ materially from those indicated by

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About RYTM

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on RYTM

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.